Three Hard Truths About California’s Fire Crisis
Climate change makes fires more dangerous. Government competence matters. And preventing catastrophic fires requires expensive, unpopular measures.
Related Articles
Prospect files for bankruptcy, leaving its hospitals in R.I. and Conn. in limbo – The Boston Globe
The filing shows Prospect had more than 100,000 creditors and between $1 billion and $10 billion in liabilities.
KRAS Mutation Status and Outcomes in Metastatic Pancreatic Adenocarcinoma
This cohort study assesses the incidence of KRAS mutations and their association with clinical outcomes based on the most common treatments used in patients with…
The promise of gene therapy approaches in SCD and barriers that remain to their implementation
In this video, Rabi Hanna, MD, Cleveland Clinic, Cleveland, OH, comments on the promise of gene therapy approaches in the treatment of sickle cell disease…
Reflections of an Inaugural Gynecologic Oncology Fellow
Nujsaubnusi Vue, MD, shares reflections on the challenges, successes, and failures that she’s encountered thus far as an inaugural fellow.
What is the truth about alcohol consumption
I take a deep dive into the question: How much alcohol should a person drink?
Putting patients first even during crisis – OncoDaily
Putting patients first even during crisis / cancer, City of Hope Comprehensive Cancer Center, OncoDaily, Oncology, Ravi Salgia, Sumanta K. Pal
When to Stay or Leave Your Physician Job – FREE Webinar
At the free, LIVE class, you’ll get everything you need to make your decision & upgrade your job in 2025, regardless if you stay or…
What is the truth about alcohol consumption
I take a deep dive into the question: How much alcohol should a person drink?
Building the future management of follicular lymphoma with T-cell–redirecting strategies
With the development of chimeric antigen receptor T-cell therapy and biologicals that engage both malignant B cells and normal T cells, the scene is set…
FDA Approves Subcutaneous Nivolumab in Advanced or Metastatic Solid Tumors
The FDA has approved nivolumab and hyaluronidase-nvhy (Opdivo Qvantig) for subcutaneous injection across approved adult solid tumor nivolumab (Opdivo) indications.
